Vortioxetine
Brand names: Trintellix
Dosage form: tablets (5mg, 10mg, 20 mg)
Drug class:
Miscellaneous antidepressants
Usage of Vortioxetine
Vortioxetine (Trintellix) is an antidepressant used to treat major depressive disorder (MDD) in adults. Vortioxetine is thought to work by increasing levels of serotonin in the brain, serotonin is a neurotransmitter. Vortioxetine's mechanism of action (MOA) is thought to be related to the inhibition of the reuptake of serotonin (5-HT), it has other activities, including 5-HT3 receptor antagonism and 5-HT1A receptor agonism, but it is unclear whether these have an antidepressant effect.
Vortioxetine is classified as a miscellaneous antidepressant, although some class vortioxetine it as a SSRI (selective serotonin reuptake inhibitor) or a serotonin modulator.
Vortioxetine originally became an FDA-approved medicine on September 30, 2013, under the brand name Brintellix. In May 2016, Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck announced that Brintellix would be marketed in the United States under the new name Trintellix effective June 2016. The change comes after receiving reports of name confusion in the marketplace between Brintellix and the anti-blood-clotting therapy Brilinta (ticagrelor).
Vortioxetine side effects
Also see Warnings below.
Common vortioxetine side effects
The most common side effects of vortioxetine that happen in more than 5% of patients and at least twice the rate of placebo in clinical trials were:
Serious vortioxetine side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Report any new or worsening symptoms to your doctor, such as mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Vortioxetine may cause serious side effects. Call your doctor at once if you have:
Serotonin syndrome is a potentially life-threatening problem that can happen when you take vortioxetine, with an increased risk with certain other medicines. Seek medical attention right away if you have symptoms of serotonin syndrome, such as agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.
Vortioxetine can cause side effects of sexual dysfunction.
This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Before taking Vortioxetine
You should not use this medicine if you have a hypersensitivity or allergy to vortioxetine.
Do not use this medicine if you have used an MAO inhibitor in the past 14 days. After you stop taking vortioxetine, you must wait at least 21 days before you start taking an MAO inhibitor.
Tell your doctor if you also take stimulant medicine, opioid medicine, herbal products, or medicine for depression, mental illness, Parkinson's disease, migraine headaches, serious infections, or prevention of nausea and vomiting. An interaction with vortioxetine could cause a serious condition called serotonin syndrome.
To make sure this medicine is safe for you, tell your doctor if you have ever had:
Pregnancy
Tell your healthcare provider if you are pregnant or plan to become pregnant, as vortioxetine may harm your unborn baby. Taking this medicine in the last 3 months of pregnancy may cause problems in the newborn, such as withdrawal symptoms, serious lung problems, or other complications in the baby. However, stopping the medicine may not be safe for you. Do not start or stop vortioxetine without asking your doctor.
There is a pregnancy registry for females who have taken vortioxetine during pregnancy. The purpose of the registry is to collect information about the health of mothers and their babies who have been exposed to vortioxetine. If you become pregnant during treatment with this medicine, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or visit online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/.
Breastfeeding
Tell your healthcare provider if you are breastfeeding or plan to breastfeed as it is not known if vortioxetine passes into breastmilk. Discuss with your doctor about the best way to feed your baby while using this medicine.
Relate drugs
- Aplenzin
- Auvelity
- Brexanolone
- Budeprion SR
- Budeprion XL
- Bupropion and dextromethorphan
- Dextromethorphan and bupropion
- Esketamine
- Esketamine nasal
- Forfivo XL
- Spravato
- Trintellix
- Viibryd
- Viibryd Titration Pack
- Vilazodone
- Vortioxetine
- Wellbutrin
- Wellbutrin SR
- Wellbutrin XL
- Zulresso
How to use Vortioxetine
Usual Adult Dose for Major Depressive Disorder:
Initial dose: 10 mg orally once a day Maintenance dose: 5 to 20 mg orally once a day Maximum dose: 20 mg/day Discontinuing treatment: at lower doses vortioxetine can be discontinued abruptly. However, for doses of 15 mg/day or 20 mg/day it is recommended if possible to reduce dose to 10 mg/day for one week prior to full discontinuation. Comments: Patients should be screened for bipolar disorder, mania, and hypomania before starting treatment. Patients who do not tolerate higher doses may be maintained on 5 mg orally once a day. The maximum recommended dose is 10 mg/day in known CYP2D6 poor metabolizers.
Formulations available
Trintellix tablets: 5 mg, 10 mg and 20 mg.
Warnings
Suicidal Thoughts and Behaviors in Adolescents and Young Adults: Some young people have thoughts about suicide when first taking an antidepressant. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor, such as mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Serotonin Syndrome: Increased risk when this medicine is used with other serotonergic agents, but there is also a risk when taken alone. Do not use vortioxetine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, methylene blue injection, phenelzine, tranylcypromine, and others. After you stop taking vortioxetine, you must wait at least 21 days before you start taking an MAO inhibitor.
Increased Bleeding Risk: Vortioxetine can increase the risk of bleeding events, and using aspirin, nonsteroidal anti-inflammatory drugs, other antiplatelet drugs, warfarin, or other drugs that affect blood clotting may increase that bleeding risk.
Discontinuation Syndrome: Adverse reactions after discontinuation of serotonergic antidepressants, particularly after a sudden discontinuation of these medicines. Whenever possible, a gradual reduction in dosage rather than abrupt cessation is recommended.
Activation of Mania/Hypomania: There is an increased risk of mania or hypomania in patients who have bipolar disorder, so it is important to screen patients for bipolar disorder, mania, or hypomania before starting treatment with this medicine.
Angle Closure Glaucoma: Angle closure glaucoma has occurred in patients with untreated anatomically narrow angles treated with antidepressants.
Low blood sodium levels (Hyponatremia): Can occur when taking some types of antidepressants and may be a result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Elderly patients may be at greater risk of developing hyponatremia with a serotonergic antidepressant. Also, patients taking diuretics or otherwise volume-depleted can be at greater risk.
Sexual Dysfunction: Vortioxetine may cause symptoms of sexual dysfunction in males and females.
What other drugs will affect Vortioxetine
Tell your doctor about all your current medicines. Many drugs can interact with vortioxetine, especially:
This list is not complete and many other drugs may interact with vortioxetine. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions